|
|
600 Cruiser Lane
Belgrade, MT 59714 USA
phone:406-388-0480
fax:406-388-0422
|
|
| Symbol |
BONE |
| Exchange |
NYSE Amex |
| Founded |
1998 |
| Employees |
168 |
|
|
| www.bacterin.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Bone graft material and anti-infective coatings for medical applications |
|
| Management |
| Guy S. Cook, Chairman of the Board, CEO, President, and Chief Scientific Office; John Gandolfo, CFO; Darrel L. Holmes - COO |
| |
|
|
|
|
|
|
|
| Keywords |
| wound, woundcare, orthopedic, medical device, skin, dermal, cartilage, grafts, tissue, regeneration, stem cells, |
|
|
|
| Description |
|
Bacterin International Holdings Inc. develops anti-microbial, anti-infective coatings for revolutionary bone graft material and also processes and markets innovative, biologic allografts for transplantation. Objectives of allograft use include pain relief, aid in tissue regeneration, and aid in bone fusion in spinal and sports medicine procedures. The Company’s biologic scaffolds OsteoSponge®, OsteoSponge® SC, and OsteoWrap® are made from demineralized bone that is malleable and flexible, which enables enhanced efficiency and precision in handling. Bacterin also markets BacFast® and OsteoLock®, which are used in spinal surgery and are designed to minimize graft back-out and increase osteoinductivity. Bacterin's latest allograft, OsteoSelect® DBM Putty, has excellent handling characteristics and is distributed as a sterile product. The aim of this later-stage medical device company is to help patients return to a healthy, active lifestyle, to help institutions reduce healthcare-associated infections, and to improve medical procedures available to soldiers in less sterile environments. |
|
| Products / Services |
Bacterin's products are divided into three main areas: biologic products, medical devices, and coating technologies. The biologic products focus on human allografts for transplantation, featuring: OsteoSponge, a 100% bone graft designed as an alternative to gels, putties and ill-fitting grafts; OsteoWrap; sports medicine allografts for ACL and PCL repairs and reconstruction as well as meniscal repair); traditional allografts and milled allografts. The medical devices currently offered are part of the Via Wound Drain Series; the upcoming second generation, called Elutia, will feature an antimicrobial coating. The coating technologies utilize various platforms to achieve results, which vary depending on the desired outcome, bioactive agent being used and substrate to be coated.
|
|
| Technology / Differentiation |
| OsteoSponge is a unique graft material designed to augment the handling properties of bone through a patent pending process. Its porous structure provides an excellent matrix for vascular growth and new bone formation. OsteoWrap is 100% human cortical bone demineralized through a proprietary process to make the graft flexible while maintaining allograft integrity. OsteoWrap can wrap around non-union fractures to assist with fusion, act as a biologic plate or in conjunction with a hardware plate system. The sports medicine grafts are irradiated to ensure patient safety. Bacterin's proprietary bioactive coating technologies are designed to prevent microbial (biofilm) attachment and growth in a variety of medical device applications and allografts. |
|
| Market / Customers |
Bacterin's products have various applications in orthopedic, neurological, trauma, oral/maxillofacial and reconstructive procedures. The allograft market is valued at $1 billion and is growing at 15-20% annually. Consequently, the company is well positioned for future growth through already established partnerships such as Broadlane as well as its direct sales force totalling 52 reps and 168 independent distributors.
|
|
| Funding |
| The Pentagon has given Bacterin $1.4 million to fight infections by coating the metal rods and pins used to treat arm and leg wounds on the battlefield. |
|
| Status |
| Bacterin received the 2009 Spine Technology Award in the Regenerative Technology Category for the proprietary biologic scaffold OsteoSponge Demineralized Bone Matrix. In 2007, Bacterin was awarded a prestigious accreditation from the American Association of Tissue Banks (AATB). |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
